Share
When Robert J. Lefkowitz, MD, received the Nobel Prize for Chemistry in 2012, that was only part of his storied career as a physician scientist. With a new book on the shelves – and online shopping carts – Lefkowitz talks to Endocrine News about misconceptions about scientists, what inspired him to write a book, and...
Share
Medical evidence, not politics, should inform treatment decisions The Endocrine Society opposes legislative efforts that do not conform to medical evidence and clinical practice to prevent transgender and gender diverse adolescents from accessing gender-affirming medical care. Arkansas passed a law April 6 prohibiting gender-affirming care for minors, the first law of its kind in the U.S. Seventeen other states...
Share
Recently, Metro Health – University of Michigan Health, an affiliate of University of Michigan Health, announced that it reduced incidence of hypoglycemia by more than 54% and experienced a 40% decline in hyperglycemia since implementing personalized insulin dosing software. Glytec is marketing the software as the eGlycemic Management System® (eGMS). Extensive research links poor glycemic control...
Share
There were no significant differences in health outcomes for pregnant women who were diagnosed with gestational diabetes or their babies using two different clinically recommended screening methods, according to results from a large-scale clinical trial conducted by Kaiser Permanente researchers and published in The New England Journal of Medicine. Although there is evidence that treating...
Share
Endocrine Society members Daniel J. Drucker, MD, and Joel Habener, MD, have been recognized with the 2021 Canada Gairdner International Award for their research on glucagon-like peptides that has led to major advances in the treatment of type 2 diabetes, obesity, and intestinal disorders. Drucker, editor-in-chief of Endocrine Reviews, is a professor in the Department...
Share
A proof-of-concept study recently published in Diabetes Care shows how inpatient diabetes technology is advancing and can provide meaningful improvements in care today and in a post-pandemic world. The research team, led by Francisco J. Pasquel, MD, MPH, assistant professor of medicine in the Division of Endocrinology at Emory University in Atlanta, write that point-of-care...
Share
Heart disease and infections rank as top causes of death among those with rare disorder Endogenous Cushing’s syndrome, a rare hormonal disorder, is associated with a threefold increase in death, primarily due to cardiovascular disease and infection, according to a study presented at ENDO 2021. The research, according to the study authors, is the largest...
Share
On March 16, the Endocrine Society conducted a “virtual” Research Hill Day where Endocrine Society members from across the U.S. met with their congressional representatives and their staff through Zoom, Skype, conference lines, and other electronic meeting platforms while the Capitol complex is closed for the pandemic and security reasons. During these meetings, Endocrine Society members urged Congress to provide an increase...
